Susquehanna International Group
GMAB icon

Susquehanna International Group’s Genmab GMAB Stock Holding History

Susquehanna International Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-612,323
Closed -$18.4M – 13506
2025
Q4 		$18.9M Buy
612,323
+594,371
+3,311% +$18.5M ﹤0.01% 2279
2025
Q3 		$551K Sell
17,952
-12,442
-41% -$303K ﹤0.01% 8737
2025
Q2 		$628K Buy
+30,394
New +$624K ﹤0.01% 8637
2025
Q1 		– Sell
-17,244
Closed -$362K – 12840
2024
Q4 		$360K Sell
17,244
-11,541
-40% -$254K ﹤0.01% 9421
2024
Q3 		$702K Sell
28,785
-19,962
-41% -$534K ﹤0.01% 7648
2024
Q2 		$1.23M Buy
48,747
+19,859
+69% +$563K ﹤0.01% 6105
2024
Q1 		$864K Buy
28,888
+12,680
+78% +$372K ﹤0.01% 7237
2023
Q4 		$516K Buy
+16,208
New +$509K ﹤0.01% 8595
2023
Q3 		– Sell
-6,147
Closed -$234K – 12357
2023
Q2 		$234K Sell
6,147
-19,614
-76% -$782K ﹤0.01% 9961
2023
Q1 		$973K Sell
25,761
-4,156
-14% -$160K ﹤0.01% 6891
2022
Q4 		$1.27M Buy
+29,917
New +$1.23M ﹤0.01% 5664
2022
Q3 		– Sell
-8,968
Closed -$315K – 13534
2022
Q2 		$291K Sell
8,968
-9,952
-53% -$322K ﹤0.01% 9637
2022
Q1 		$685K Sell
18,920
-12,517
-40% -$430K ﹤0.01% 8140
2021
Q4 		$1.24M Sell
31,437
-29,309
-48% -$1.22M ﹤0.01% 6695
2021
Q3 		$2.65M Buy
60,746
+51,220
+538% +$2.3M ﹤0.01% 5220
2021
Q2 		$389K Sell
9,526
-55,596
-85% -$2.15M ﹤0.01% 10204
2021
Q1 		$2.14M Buy
65,122
+4,937
+8% +$186K ﹤0.01% 5769
2020
Q4 		$2.45M Sell
60,185
-7,644
-11% -$286K ﹤0.01% 4682
2020
Q3 		$2.48M Buy
67,829
+19,801
+41% +$716K ﹤0.01% 4210
2020
Q2 		$1.63M Buy
48,028
+38,486
+403% +$1.05M ﹤0.01% 4868
2020
Q1 		$202K Sell
9,542
-875
-8% -$19.5K ﹤0.01% 8669
2019
Q4 		$233K Buy
+10,417
New +$227K ﹤0.01% 8492

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Susquehanna International Group's GMAB Position: Q1 2026 in Review

Susquehanna International Group sold out of Genmab (GMAB) in Q1 2026, closing a stake of 612,323 shares — an estimated $18.4M sold.

Susquehanna International Group first reported a position in GMAB in Q4 2019 and held it in 22 quarters. The position peaked at $18.9M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Susquehanna International Group reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 612,323 Genmab shares in Q1 2026, an estimated $18.4M.
  • Susquehanna International Group first reported a position in Genmab in Q4 2019 and held it in 22 quarters.
  • Susquehanna International Group's Genmab position peaked at $18.9M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.